ConductScience.org, home

Gene · 7939

NIH grants1,570

NIH grants whose papers are about the gene, through NIH's grant-paper links.

501 to 520 of 1,570

Download this page as JSON
GrantTitleLAP papersNewest fiscal year
R01AI136972Genetic regulation and immunological function of ERAP2 haplotypes12022
R01AR062947Enhanced Tendon Healing Through Growth Factor and Cell Therapies12022
R01AR071734GP130/STAT3 signalling in articular cartilage development and regeneration12022
R01CA120439Small Molecule Activators of Procaspases as Anti-Cancer Agents12022
R01CA167291Exploiting the Ref-1 node in pancreatic cancer: tailoring new pancreatic cancer therapy using multi-targeted combinations12022
R01CA211098Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma disease12022
R01CA224769Integrin-mediated mechanisms of prostate cancer progression12022
R01CA227136Modeling and druggable-genome screening of glioblastoma invasion using regional biopsy-guided biomaterials systems12022
R01CA231880The pathogenesis of chromosome 7q deletions in juvenile myelomonocytic leukemia12022
R01CA232517Engineered ECM platforms to analyze progression in high grade serous ovarian cancer12022
R01DA047157A new pathway of spinal neurons in neuropathic pain induced by HIV with opioid12022
R01DE013349Engineering Skeletal Muscle WIth Biodegradable Hydrogels12022
R01DE027980Human Herpesvirus Impact on Periodontal Inflammation12022
R01DE028172T cell plasticity, fusion proteins and CAR T cell-based immunotherapy of head and neck cancer12022
R01DK098410Modeling Nephrotic Syndrome in Drosophila Nephrocytes12022
R01DK118940Cellular mechanobiology and engineering of active brown adipose tissue12022
R01DK120908Integrating Drosophila and human podocyte studies to discover APOL1 renal toxicity mechanism and therapeutic targets12022
R01EB023052Engineering a naturally derived and highly adhesive surgical sealant12022
R01EY023295Neuroprotection by Modulating ER Stress in Glaucoma12022
R01HL113326Characterization of European American and African American Sarcoidosis via Immunogenetics12022

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/7939/grants?page=26